Trials / Unknown
UnknownNCT05749445
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients: a Multicenter Retrospective Study in China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- First People's Hospital of Hangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nirmatrelvir-Ritonavir | Nirmatrelvir-Ritonavir |
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
- First posted
- 2023-03-01
- Last updated
- 2023-03-01
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05749445. Inclusion in this directory is not an endorsement.